GSTM1 and Schnyder corneal dystrophy: 5HMF has previously been studied in the clinic for the treatment of SCD as a result of its ability to stabilize the high-O2-affinity R-state Hb, and increase the concentration of the non-polymerizing oxygenated HbS [26,27].